Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for pain reduction in Critical Limb Ischemia
2005-004128-38Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pregabalin in arteriosclerosis obliterans, sponsored by Karolinska University Hospital. Primary endpoint: Pain rating after two weeks of treatment. Started Dec 2005; status: active.
02
Drugs
pregabalin
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2005-004128-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004128-38.